Yousef Abou Allaban, MD
Psychiatry · Walpole, MANPI 1922040666
Payments from drug & device makers
Across 512 payments — averaging $91.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$38K
- Otsuka America Pharmaceutical, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$948
- AbbVie$808
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$597
- plus $3K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 104 | $37,569 |
| Otsuka America Pharmaceutical, Inc. | 58 | $2,165 |
| Teva Pharmaceuticals USA, Inc. | 57 | $1,241 |
| Neurocrine Biosciences, Inc. | 47 | $948 |
| AbbVie(2 entities) | 50 | $808 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $597 |
| Vanda Pharmaceuticals Inc. | 34 | $592 |
| Alkermes, Inc. | 32 | $568 |
| Lundbeck LLC | 29 | $541 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $272 |
| Axsome Therapeutics, Inc. | 11 | $266 |
| Sunovion Pharmaceuticals Inc. | 9 | $245 |
| E.r. Squibb & Sons, L.L.C. | 7 | $169 |
| Ironshore Pharmaceuticals Inc. | 6 | $128 |
| Corium, LLC | 5 | $118 |
| Tempus AI, Inc | 3 | $87 |
| Livanova USA, Inc. | 1 | $54 |
| Acadia Pharmaceuticals Inc | 2 | $53 |
| Shire North American Group Inc | 3 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Almatica Pharma LLC | 1 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
How this compares
$46,675 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Walpole
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
- Marc ShayAmesbury$1.7M
- Martha StarkNewton$1.6M
- Hadine JoffeBoston$1.5M
- Malini NairWinchester$1M
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.